Shares of Baxter International (BAX) Sees Large Inflow of Net Money Flow

Baxter International (BAX) : On Monday, The money flowed into the Baxter International (BAX) stock with an uptick to downtick ratio was recorded at 1.38. Transactions worth $29.89 million were done on upticks, confirming the buying interest in the stock. The outflow of money on downticks stood at $21.59 million. The total money flow into the stock was $8.29 million. The block trades reveal a bullish bias with an up-down ratio of 3.64. The investors are using every small weakness in the stock to accumulate it, as can be seen in the $11.99 million of block transactions on upticks. The value of block trades on downticks was $3.3 million, indicating lower selling interest. The total money flow in block trades was $8.7 million. In terms of price action, Baxter International (BAX) traded down $0.22 during the session at $46.55. Compared to the previous days closing, the stock was down only by -0.47%. For the week, the stock is -0.21%, over previous weeks closing.


Baxter International Inc. is up 8.33% in the last 3-month period. Year-to-Date the stock performance stands at 22.74%. Shares of Baxter International Inc. rose by 0.13% in the last five trading days and 4.44% for the last 4 weeks. In a related news, Almeida Jose E, CEO of Baxter International Inc had purchased 11,691 shares on May 23, 2016 in a transaction. The price per share was $42.75 and the total amount of the disclosed transaction was $499,790.The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing. This information is based on open market transaction at the market prices.

Baxter International (NYSE:BAX): On Mondays trading session , Opening price of the stock was $46.81 with an intraday high of $46.86. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $46.34. However, the stock managed to close at $46.55, a loss of 0.47% for the day. On the previous day, the stock had closed at $46.77. The total traded volume of the day was 2,811,905 shares.

Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment, which include three commercial franchises: Hemophilia, BioTherapeutics and BioSurgery, and Medical Products segment, which include four commercial franchises: Fluid Systems, Renal, Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions, and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps and inhalation anesthetics. Its products are used in hospitals, kidney dialysis centers and nursing homes, among others.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.